RXi Pharmaceuticals Corporation (RXII) climbed 5.44% or 0.13 to $2.52. It is nearly 164057 shares traded, which is 47.73% compare to the average total volume 343684. The market cap of RXII is $10.72 million. The year to date change is 487.35%. The 52 week price range is from $1.9 to $7.7. Price of RXII have changed 8.21% during last week. It have changed -2.85% over last month, -6.27% over last 3 months, -59.50% over last 6 months and -56.63% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 2.69. It is 6.75% above current price. The 200-day Moving Averages for RXII is 4.40. It is 74.60% above current price. The 52-week High is 7.7. It is 205.56% from the current price. The 52-week Low is 1.9. It is -24.60% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 1.4 on 2018-05-15. Short % to float is 17.29%. There are some statistics of RXII. It is has market cap $10.72 million. The share outstanding is 4.26 million. The average volume is 343684. The percent of top 15 Institution holding is 32.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -182.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -121.02%.